{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:23:06Z","timestamp":1790292186621,"version":"4.1.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular disease remains the leading cause of global morbidity and mortality and arises from complex interactions among metabolic dysregulation, inflammation, thrombosis, and vascular dysfunction. In recent years, the gut microbiota has emerged as an important regulator of cardiovascular pathophysiology, largely through the production of bioactive metabolites that act on distant organs. This review summarizes the major classes of gut microbiota-derived metabolites involved in cardiovascular disease, with particular emphasis on trimethylamine N-oxide, short-chain fatty acids, phenylacetylglutamine, bile acids, and tryptophan-derived metabolites. We discuss how these metabolites influence endothelial dysfunction, immune activation, lipid handling, platelet reactivity, cardiac remodeling, gut barrier integrity, and blood pressure regulation through interconnected signaling pathways. We further examine their disease-specific relevance in atherosclerosis, heart failure, hypertension, and coronary artery disease\/acute coronary syndrome. In addition, we evaluate current translational strategies targeting microbial metabolism, including dietary modulation, probiotics and prebiotics, fecal microbiota transplantation, and selective inhibition of microbial enzymes. Rather than viewing individual metabolites as uniformly harmful or protective, we propose that cardiovascular risk is better understood as the net consequence of interacting microbial metabolic pathways within specific host contexts. This metabolite-centered framework may help refine biomarker development, risk stratification, and pathway-guided interventions in cardiovascular medicine.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1884283","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:14Z","timestamp":1784780894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut microbiota-derived metabolites in cardiovascular disease: mechanisms, disease-specific roles, and translational opportunities"],"prefix":"10.3389","volume":"13","author":[{"given":"Guanqun","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Siping City Central People\u2019s Hospital","place":["Siping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiu","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Siping City Central People\u2019s Hospital","place":["Siping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.31083\/j.rcm2405134","article-title":"Non-Traditional risk factors as contributors to cardiovascular disease","volume":"24","author":"Wang","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s44155-026-00405-7","article-title":"Global and Indian cardiovascular disease mortality dynamics across multiregional epidemiological transitions differential risk factor burdens and integrated policy frameworks for advancing sustainable development goal 3.4","volume":"6","author":"Gull","year":"2026","journal-title":"Discover Social Science and Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1700540","DOI":"10.3389\/fcvm.2025.1700540","article-title":"Global trends of cardiovascular disease burden attributable to high body mass index from 1990 to 2021 and projections to 2035","volume":"12","author":"Huang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3389\/fcvm.2026.1695600","article-title":"Global burden and trend of ischemic heart disease and its attributable risk factors among women of childbearing age from 1990 to 2021","volume":"13","author":"Liu","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s44324-024-00028-z","article-title":"Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology","volume":"2","author":"Zhang","year":"2024","journal-title":"NPJ Metab Health Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s43856-025-01353-0","article-title":"Plasma and pericardial fluid metabolomic signatures of patients with ischemic heart disease","volume":"6","author":"De Castro","year":"2026","journal-title":"Commun Med (Lond)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/genes17010116","article-title":"Composition and function of gut microbiome: from basic omics to precision medicine","volume":"17","author":"Ma","year":"2026","journal-title":"Genes (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"G122","DOI":"10.1152\/ajpgi.00016.2025","article-title":"Gut-heart axis: cardiac remodeling and heart failure in the context of inflammatory bowel disease and dysbiosis","volume":"329","author":"Kochkarian","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fcvm.2025.1572948","article-title":"The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/nu18030467","article-title":"Dietary nutrients, gut Microbiota, and cardiac function: from metabolic mechanisms to clinical applications","volume":"18","author":"Scisciola","year":"2026","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/CM9.0000000000002206","article-title":"Gut microbiota and microbiota-derived metabolites in cardiovascular diseases","volume":"136","author":"Chen","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","article-title":"Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway","volume":"97","author":"Geng","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway","volume":"6","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/CIRCRESAHA.114.305680","article-title":"TMAO Is both a biomarker and a renal toxin","volume":"116","author":"Fogelman","year":"2015","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/2175-8239-JBN-2023-0065en","article-title":"Trimethylamine N-oxide and kidney diseases: what do we know?","volume":"46","author":"Gungor","year":"2024","journal-title":"J Bras Nefrol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1488264","DOI":"10.3389\/fcimb.2025.1488264","article-title":"The microbial metabolite trimethylamine N-oxide and the kidney diseases","volume":"15","author":"Su","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-Fiber diet and acetate supplementation change the gut Microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e91579","DOI":"10.7759\/cureus.91579","article-title":"Fecal short-chain fatty acids (SCFAs) and their role in metabolic disorders: a systematic review","volume":"17","author":"Ahmad","year":"2025","journal-title":"Cureus"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/HYPERTENSIONAHA.122.18558","article-title":"Short-Chain fatty acid receptors and blood pressure regulation: council on hypertension mid-career award for research excellence 2021","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.bpr.2026.100260","article-title":"Effect of the gut microbiota metabolite phenylacetylglycine on cardiac ca(2+) signaling","volume":"6","author":"Bovo","year":"2026","journal-title":"Biophys Rep (N Y)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","article-title":"A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors","volume":"180","author":"Nemet","year":"2020","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 Activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut Microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.3390\/ijms23126719","article-title":"Aryl hydrocarbon receptor in oxidative stress as a double agent and its biological and therapeutic significance","volume":"23","author":"Grishanova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2575434","DOI":"10.1080\/0886022X.2025.2575434","article-title":"Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complications","volume":"47","author":"Lei","year":"2025","journal-title":"Ren Fail"},{"key":"B45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4161\/gmic.27492","article-title":"A novel SCFA receptor, the microbiota, and blood pressure regulation","volume":"5","author":"Pluznick","year":"2014","journal-title":"Gut Microbes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s13668-024-00531-1","article-title":"Management of cardiovascular diseases by short-chain fatty acid postbiotics","volume":"13","author":"Mousavi Ghahfarrokhi","year":"2024","journal-title":"Curr Nutr Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1689026","DOI":"10.3389\/fmicb.2025.1689026","article-title":"Bile acid-microbiota interactions in cardiometabolic diseases: mechanisms and emerging therapeutic approaches","volume":"16","author":"Chen","year":"2025","journal-title":"Front Microbiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ymeth.2023.12.007","article-title":"Microbiome metabolite quantification methods enabling insights into human health and disease","volume":"222","author":"Roach","year":"2024","journal-title":"Methods"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1343572","DOI":"10.3389\/fmicb.2024.1343572","article-title":"A comprehensive overview of microbiome data in the light of machine learning applications: categorization, accessibility, and future directions","volume":"15","author":"Kumar","year":"2024","journal-title":"Front Microbiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"107999","DOI":"10.1016\/j.isci.2023.107999","article-title":"Intestinal microbial circadian rhythms drive sex differences in host immunity and metabolism","volume":"26","author":"Munyoki","year":"2023","journal-title":"iScience"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00261-19","article-title":"Age- and sex-dependent patterns of gut microbial diversity in human adults","volume":"4","author":"De La Cuesta-Zuluaga","year":"2019","journal-title":"mSystems"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/ph18091372","article-title":"Drugs versus Microbiota: how pharmacotherapy affects gut and probiotic Bacteria","volume":"18","author":"Zawistowska-Rojek","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"goac009","DOI":"10.1093\/gastro\/goac009","article-title":"Interplays between drugs and the gut microbiome","volume":"10","author":"Wan","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2644681","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2016.11.017","article-title":"Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome","volume":"481","author":"Sun","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"123528","DOI":"10.1016\/j.lfs.2025.123528","article-title":"Advancements in the study of short-chain fatty acids and their therapeutic effects on atherosclerosis","volume":"369","author":"Wang","year":"2025","journal-title":"Life Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.22038\/ijbms.2025.82302.17799","article-title":"Bacterial endotoxin-lipopolysaccharide role in inflammatory diseases: an overview","volume":"28","author":"Arya","year":"2025","journal-title":"Iran J Basic Med Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1186892","DOI":"10.3389\/fimmu.2023.1186892","article-title":"Regulation of short-chain fatty acids in the immune system","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"152398","DOI":"10.1016\/j.seminoncol.2025.152398","article-title":"The effects of microbiota-derived short-chain fatty acids on T lymphocytes: from autoimmune diseases to cancer","volume":"52","author":"Saadh","year":"2025","journal-title":"Semin Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut Microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/medicina61101767","article-title":"TMAO And cardiovascular disease: exploring its potential as a biomarker","volume":"61","author":"Amaritei","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"107806","DOI":"10.1016\/j.phrs.2025.107806","article-title":"Interaction between gut-heart axis in sepsis-induced cardiomyopathy","volume":"217","author":"Zhou","year":"2025","journal-title":"Pharmacol Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fphys.2024.1380713","article-title":"Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise","volume":"15","author":"Dmytriv","year":"2024","journal-title":"Front Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1710051","DOI":"10.3389\/fmicb.2025.1710051","article-title":"The bidirectional regulatory mechanism of gut microbiota metabolites on myocardial injury in heart failure from the perspective of the gut-heart axis: a review","volume":"16","author":"Guo","year":"2025","journal-title":"Front Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3389\/fphys.2019.00866","article-title":"Trimethylamine N-oxide exacerbates cardiac fibrosis via activating the NLRP3 inflammasome","volume":"10","author":"Li","year":"2019","journal-title":"Front Physiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","article-title":"Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure","volume":"9","author":"Organ","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B71","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/j.atherosclerosis.2017.06.386","article-title":"Effect of bile acid receptor (FXR\/TGR5) agonist INT-767 on peripheral immune cells","volume":"263","author":"Papackova","year":"2017","journal-title":"Atherosclerosis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"B74","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","article-title":"Trimethylamine-N-Oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-\u03baB (nuclear factor \u03baB) signals","volume":"40","author":"Zhang","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1271001","DOI":"10.3389\/fphar.2023.1271001","article-title":"Short-chain fatty acids are potential goalkeepers of atherosclerosis","volume":"14","author":"Feng","year":"2023","journal-title":"Front Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5694\/mja2.50781","article-title":"Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure","volume":"213","author":"Li","year":"2020","journal-title":"Med J Aust"},{"key":"B78","doi-asserted-by":"publisher","first-page":"864600","DOI":"10.3389\/fcvm.2022.864600","article-title":"Targeting trimethylamine N-oxide: a new therapeutic strategy for alleviating atherosclerosis","volume":"9","author":"Jing","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-Chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fcvm.2024.1333005","article-title":"Gut microbiota: a potential new regulator of hypertension","volume":"11","author":"Ge","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0300869","DOI":"10.1371\/journal.pone.0300869","article-title":"Effects of fecal microbiota transfer on blood pressure in animal models: a systematic review and meta-analysis","volume":"19","author":"Lin","year":"2024","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3390\/nu17172887","article-title":"Targeting gut Microbiota to combat vascular aging and cardiovascular disease: mechanisms and therapeutic potential","volume":"17","author":"Li","year":"2025","journal-title":"Nutrients"},{"key":"B84","doi-asserted-by":"publisher","first-page":"G355","DOI":"10.1152\/ajpgi.00099.2021","article-title":"Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels","volume":"321","author":"Jaworska","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","article-title":", salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1161\/CIRCRESAHA.125.326065","article-title":"Fiber, fatty acids, and blood pressure: a gut-level solution","volume":"136","author":"Khan","year":"2025","journal-title":"Circ Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fcvm.2022.900381","article-title":"Microbiota-derived short-chain fatty acids: implications for cardiovascular and metabolic disease","volume":"9","author":"Lu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/HYPERTENSIONAHA.115.06417","article-title":"Role of bile acid-regulated nuclear receptor FXR and G protein-coupled receptor TGR5 in regulation of cardiorenal syndrome (cardiovascular disease and chronic kidney disease)","volume":"67","author":"Levi","year":"2016","journal-title":"Hypertension"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front Nutr"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3389\/fphar.2019.01360","article-title":"Gut Microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target","volume":"10","author":"Yang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"key":"B93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.livres.2025.02.001","article-title":"Probiotic Bifidobacterium reduces serum TMAO in unstable angina patients via the gut to liver to heart axis","volume":"9","author":"Zhou","year":"2025","journal-title":"Liver Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"9240146","DOI":"10.26599\/FSAP.2026.9240146","article-title":"Probiotics and cholesterol metabolism: new frontiers in science from intestinal microecology to cardiovascular health","volume":"4","author":"Li","year":"2026","journal-title":"Food Sci Anim Prod"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.fshw.2023.02.005","article-title":"Role of intestinal probiotics in the modulation of lipid metabolism: implications for therapeutic treatments","volume":"12","author":"Song","year":"2023","journal-title":"Food Sci Hum Wellness"},{"key":"B96","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12916-025-04189-6","article-title":"Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight\/obese and healthy individuals: a randomized, double-blind clinical trial","volume":"23","author":"Li","year":"2025","journal-title":"BMC Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/gels11100829","article-title":"Techno-Functional properties and applications of inulin in food systems","volume":"11","author":"Canazza","year":"2025","journal-title":"Gels"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1695840","DOI":"10.3389\/fimmu.2025.1695840","article-title":"The crosstalk between probiotics and T cell immunity","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1671152","DOI":"10.3389\/fcell.2025.1671152","article-title":"Probiotics and the intestinal tight junction barrier function","volume":"13","author":"Ferris","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e9679","DOI":"10.1097\/MD.0000000000009679","article-title":"The effects of probiotics on total cholesterol: a meta-analysis of randomized controlled trials","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"104663","DOI":"10.1016\/j.phrs.2020.104663","article-title":"Effect of lactobacillusplantarum containing probiotics on blood pressure: a systematic review and meta-analysis","volume":"153","author":"Lewis-Mikhael","year":"2020","journal-title":"Pharmacol Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2644677","DOI":"10.1080\/19490976.2026.2644677","article-title":"Gut microbiome and metabolic health: mechanisms and precision interventions","volume":"18","author":"Li","year":"2026","journal-title":"Gut Microbes"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2623359","DOI":"10.1080\/19490976.2026.2623359","article-title":"Precise probiotic therapy: advances, bottlenecks, and the road to microbiome-informed nutrition","volume":"18","author":"Jiang","year":"2026","journal-title":"Gut Microbes"},{"key":"B104","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2020.09.038","article-title":"Fecal Microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry","volume":"160","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.12998\/wjcc.v11.i19.4612","article-title":"Fecal microbiota transplantation in patients with metabolic syndrome and obesity: a randomized controlled trial","volume":"11","author":"Da Ponte Neto","year":"2023","journal-title":"World J Clin Cases"},{"key":"B106","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/J.Cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal Microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"key":"B107","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s12276-022-00728-w","article-title":"Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q\/TNF-related protein 9 genetic deficiency","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/J.Cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jth.14234","article-title":"Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk","volume":"16","author":"Zhu","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B112","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/MOL.0000000000000215","article-title":"Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis","volume":"26","author":"Schugar","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"113247","DOI":"10.1016\/j.isci.2025.113247","article-title":"Role of gut microbiota and derived metabolites in cardiovascular diseases","volume":"28","author":"Yu","year":"2025","journal-title":"iScience"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e043087","DOI":"10.1161\/JAHA.125.043087","article-title":"Metabolomic biomarkers are independently associated with secondary adverse cardiovascular events in patients with coronary artery disease","volume":"14","author":"Osei","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B115","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3897\/folmed.66.e132325","article-title":"Effect of Lactobacillus plantarum supplementation on trimethylamine-N-oxide levels in 30 patients with atherosclerotic cardiovascular disease: a double-blind randomized controlled trial","volume":"66","author":"Spasova","year":"2024","journal-title":"Folia Med (Plovdiv)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1632435","DOI":"10.3389\/fmicb.2025.1632435","article-title":"The human microbiome in clinical translation: from bench to bedside","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Microbiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmi.2026.01.021","article-title":"Microbiome research in practice: priorities for clinical translation and impact","volume":"32","author":"Theodosiou","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.3390\/nu16223806","article-title":"Unraveling the gut Microbiota: implications for precision nutrition and personalized medicine","volume":"16","author":"Abeltino","year":"2024","journal-title":"Nutrients"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1884283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:16Z","timestamp":1784780896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1884283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":118,"alternative-id":["10.3389\/fcvm.2026.1884283"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1884283","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1884283"}}